BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17560277)

  • 1. Role of AID in tumorigenesis.
    Okazaki IM; Kotani A; Honjo T
    Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation-induced deaminase: light and dark sides.
    de Yébenes VG; Ramiro AR
    Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of AID leads to tumorigenesis.
    Okazaki IM; Hiai H; Kakazu N; Yamada S; Muramatsu M; Kinoshita K; Honjo T
    J Exp Med; 2003 May; 197(9):1173-81. PubMed ID: 12732658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
    Pérez-Durán P; de Yebenes VG; Ramiro AR
    Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AID and Igh switch region-Myc chromosomal translocations.
    Unniraman S; Schatz DG
    DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.
    Wakae K; Magor BG; Saunders H; Nagaoka H; Kawamura A; Kinoshita K; Honjo T; Muramatsu M
    Int Immunol; 2006 Jan; 18(1):41-7. PubMed ID: 16291656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
    Popov SW; Moldenhauer G; Wotschke B; Brüderlein S; Barth TF; Dorsch K; Ritz O; Möller P; Leithäuser F
    Cancer Res; 2007 Jul; 67(14):6555-64. PubMed ID: 17638864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID targeting in antibody diversity.
    Pavri R; Nussenzweig MC
    Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of activation-induced deaminase in antibody diversification and chromosome translocations.
    Ramiro A; Reina San-Martin B; McBride K; Jankovic M; Barreto V; Nussenzweig A; Nussenzweig MC
    Adv Immunol; 2007; 94():75-107. PubMed ID: 17560272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc.
    Unniraman S; Zhou S; Schatz DG
    Nat Immunol; 2004 Nov; 5(11):1117-23. PubMed ID: 15489857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of chromosomal translocations in B cell lymphomas.
    Küppers R; Dalla-Favera R
    Oncogene; 2001 Sep; 20(40):5580-94. PubMed ID: 11607811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.
    Smit LA; Bende RJ; Aten J; Guikema JE; Aarts WM; van Noesel CJ
    Cancer Res; 2003 Jul; 63(14):3894-8. PubMed ID: 12873980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching on chromosomal translocations.
    Ramiro AR; Nussenzweig MC; Nussenzweig A
    Cancer Res; 2006 Aug; 66(16):7837-9. PubMed ID: 16912154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AID is required for c-myc/IgH chromosome translocations in vivo.
    Ramiro AR; Jankovic M; Eisenreich T; Difilippantonio S; Chen-Kiang S; Muramatsu M; Honjo T; Nussenzweig A; Nussenzweig MC
    Cell; 2004 Aug; 118(4):431-8. PubMed ID: 15315756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apex2 is required for efficient somatic hypermutation but not for class switch recombination of immunoglobulin genes.
    Sabouri Z; Okazaki IM; Shinkura R; Begum N; Nagaoka H; Tsuchimoto D; Nakabeppu Y; Honjo T
    Int Immunol; 2009 Aug; 21(8):947-55. PubMed ID: 19556307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
    Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.